Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Upcoming valuation on a jv deal

<< Previous

Bullboard Posts

Next >>

Comment by jmm1228on Aug 29, 2023 11:19am

182 Views

Post# 35609849

RE:RE:RE:Upcoming valuation on a jv deal

It will ben difficult to craft a JV between a Pharm powerhouse and this fledgling company with no demonstrated ability to manufacture, market and support this vital, breakthrough invention. Whomever brings Ruvidar to market will want to be fully in control. TLTs present team does not have the depth heeded to accomplish a successful launch. My opinion, I have no information to support this.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”